info icon

Intracranial nontraumatic haemorrhage of fetus and newborn

P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 P52
  • Cause of death: ICD-10 P52

2 out of 7 registries used, show all original rules.

50

4. Check minimum number of events

None

50

5. Include endpoints

None

50

6. Filter based on genotype QC (FinnGen only)

50

Control definitions (FinnGen only)

Control exclude
P16_HAEMORRHAGIC_HAEMATOL_DISORD_FETUS_NEWBO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P[5-6]
Name in latin
Haemorrhagia intracranialis non traumatica fetus sive neonati

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2780 1110 1670
Only index persons 1118 439 679
Unadjusted period prevalence (%)
Whole population 0.04 0.03 0.05
Only index persons 0.02 0.02 0.03
Median age at first event (years)
Whole population - 0.00 0.00
Only index persons 0.00 0.00 0.00

-FinnGen-

Key figures

All Female Male
Number of individuals 50 28 22
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 0.00 0.00 0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
10
12.25
8.94
4.2
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
12
22
6.86
6.65
4.4
8.4
mg/l
651.3
341.6
0.64
12
22
(3044290) Cell count panel - Cerebral spinal fluid
11
21
6.43
5.82
4.8
8.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
9
10
10.66
5.02
3.7
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
10
21
5.70
4.76
4.8
8.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
15
46
4.23
4.63
2.6
1.2
pmol/l
100.1
101.4
—
7
25
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
10
22
5.43
4.53
4.5
8.4
mmol/l
2.7
3.3
—
10
22
(3022313) Gas panel - Capillary blood
26
125
3.25
4.04
27.5
9.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
13
40
4.04
3.95
2.9
2.0
u/l
713.5
204.6
0.85
13
40
(3023368) Bacteria identified in Blood by Culture
18
70
3.46
3.92
7.8
4.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
8
13
7.09
3.66
2.3
2.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
140
3.02
3.58
28.4
9.1
mmol/l
1.2
1.0
0.22
20
105
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
26
134
2.96
3.46
28.8
9.0
mmol/l
23.7
24.2
0.35
26
134
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
7
9.52
3.36
2.5
1.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
15
6.12
3.34
3.4
2.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
11
7.19
3.30
1.3
9.4
%
104.7
84.8
—
7
11
(3016018) Differential panel - Cerebral spinal fluid
8
16
5.73
3.20
4.4
7.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
8
8.32
3.14
2.5
1.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
8
8.32
3.14
2.7
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7
12
6.58
3.14
1.0
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
12
41
3.54
3.11
5.3
12.6
g/l
2.1
2.7
1.39
12
41
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
17
5.38
3.06
3.4
2.4
—
—
—
0
0
(44790049)
9
22
4.75
3.05
1.8
2.4
—
—
—
0
0
(44790048)
9
22
4.75
3.05
1.8
2.4
—
—
—
0
0
(44790047)
9
22
4.75
3.05
1.8
2.4
—
—
—
0
0
(44806118)
9
22
4.75
3.05
1.8
2.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
12
42
3.44
2.99
5.5
11.8
%
101.8
167.1
4.17
12
42
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
13
6.06
2.98
1.9
2.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
23
4.53
2.94
2.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
23
4.53
2.94
3.3
2.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
23
4.53
2.94
2.4
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
18
5.07
2.93
3.9
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
37
3.53
2.90
2.4
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
24
4.33
2.83
3.3
2.4
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
5
6
9.07
2.81
4.0
10.2
mg/l
21.0
10.5
—
5
6
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
5
6
9.07
2.81
1.2
1.8
%
67.4
91.2
—
5
6
(42870588) Differential panel, method unspecified - Blood
33
212
2.64
2.64
12.5
14.0
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
6
11
6.02
2.62
4.0
4.5
umol/l
1.4
1.4
—
6
11
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
7
7.77
2.61
1.2
1.3
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
5
7
7.77
2.61
3.2
5.6
mmol/l
21.3
13.8
—
5
7
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
34
3.43
2.58
2.4
1.3
—
—
—
0
0
(3013512) EKG study
9
27
3.83
2.54
1.7
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
55
2.84
2.36
3.5
2.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
5
9
6.02
2.27
5.2
3.4
umol/l
476.2
415.4
—
5
9
(3000494) Fungus identified in Specimen by Culture
9
31
3.31
2.20
1.9
1.5
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
5
10
5.41
2.12
4.4
4.3
mmol/l
4.2
2.6
—
5
10
(3044640) Blood type and Crossmatch panel - Blood
18
95
2.40
2.10
4.8
4.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
13
59
2.63
2.05
3.3
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
34
3.00
1.98
1.1
2.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
11
47
2.72
1.94
3.5
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
11
47
2.72
1.94
3.6
2.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
19
107
2.25
1.89
3.1
4.9
mg/l
2.5
2.6
0.09
19
92
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
16
85
2.30
1.81
4.1
4.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
26
170
2.10
1.76
10.3
12.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
19
3.44
1.72
2.0
1.5
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
36
269
2.21
1.69
12.8
13.7
e9/l
0.2
0.2
0.31
31
216
(3000991) Gas panel - Venous blood
20
121
2.09
1.63
11.8
12.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
33
2.69
1.62
2.1
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
15
3.58
1.56
2.2
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
5
15
3.58
1.56
1.2
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
29
2.64
1.45
1.3
2.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
7
29
2.64
1.45
1.3
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
62
2.23
1.42
1.4
1.9
—
—
—
0
0
(3024731) MCV [Entitic volume]
50
463
+∞
1.41
32.6
17.7
fl
86.0
84.7
0.88
50
457
(3035941) MCH [Entitic mass]
50
463
+∞
1.41
32.6
17.7
pg
29.1
28.5
0.99
50
457
(3000963) Hemoglobin [Mass/volume] in Blood
50
463
+∞
1.41
33.4
18.0
g/l
132.3
129.1
0.56
50
457
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
17
3.15
1.39
1.0
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
5
17
3.15
1.39
2.0
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
19
119
1.96
1.38
2.1
1.7
—
—
—
0
0
(4035726)
5
18
2.97
1.31
2.0
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
28
203
1.86
1.29
1.9
2.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
19
2.81
1.24
3.8
5.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
19
2.81
1.24
3.8
5.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
30
226
1.82
1.19
9.2
4.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
22
151
1.82
1.19
3.6
2.8
mmol/l
0.9
1.1
1.91
22
143
(1175426) CD3 cells/100 lymphocytes in Blood
5
20
2.66
1.18
3.8
5.3
%
64.4
69.6
—
5
20
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
20
2.66
1.18
1.2
3.9
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
20
135
1.80
1.13
5.0
4.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
22
155
1.75
1.07
12.6
5.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
10
54
2.06
1.05
3.6
5.0
g/l
11.1
7.6
—
10
54
(3001604) Monocytes [#/volume] in Blood
33
265
1.72
0.97
12.6
12.3
e9/l
0.5
0.6
0.69
27
205
(3006315) Basophils [#/volume] in Blood
33
265
1.72
0.97
12.6
12.3
e9/l
0.0
0.0
0.21
27
205
(3030467) Casts [#/volume] in Urine by Automated count
20
141
1.70
0.95
13.6
5.3
e6/l
1.1
0.1
0.44
12
104
(3026008) Bacteria identified in Urine by Culture
14
89
1.80
0.94
9.5
3.0
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
28
217
1.66
0.93
10.8
4.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
45
403
2.16
0.90
25.6
11.7
mg/l
29.2
25.3
0.24
29
271
(40768797) Stomach Pathology biopsy report
6
31
2.06
0.87
1.7
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
22
162
1.64
0.87
39.4
16.8
mmol/l
25.1
24.7
0.29
22
162
(3019198) Lymphocytes [#/volume] in Blood
33
270
1.65
0.86
12.7
12.2
e9/l
2.3
2.8
1.04
28
219
(3013650) Neutrophils [#/volume] in Blood by Automated count
34
281
1.66
0.84
14.0
14.2
e9/l
2.7
3.4
1.29
28
223
(3021589) Normoblasts [#/volume] in Blood
33
272
1.63
0.81
14.8
13.5
e9/l
0.0
0.1
0.46
28
193
(3024354) Oxygen [Partial pressure] in Venous blood
18
128
1.63
0.81
12.1
14.0
kpa
5.1
5.3
0.20
18
128
(3002582) Erythrocytes [#/volume] in Urine
20
149
1.57
0.74
13.6
5.1
e6/l
16.6
55.0
0.90
12
111
(3018095) Leukocytes [#/volume] in Urine
22
168
1.55
0.73
15.2
6.1
e6/l
90.5
25.2
0.39
12
112
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
5
26
2.02
0.73
6.0
2.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
19
142
1.55
0.68
14.1
5.2
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
7
44
1.69
0.68
3.7
22.4
mmol/l
107.7
105.8
—
7
44
(3035933) Granulocytes/100 leukocytes in Blood
0
20
0.00
0.62
0.0
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
6
35
1.81
0.60
1.2
1.4
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
17
128
1.50
0.58
11.3
12.5
mmol/l
24.2
23.3
1.13
17
120
(3011397) Hemoglobin [Presence] in Urine by Test strip
14
102
1.52
0.55
4.8
3.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
10
67
1.62
0.54
10.0
4.1
—
—
—
0
0
(3015736) pH of Urine
16
121
1.47
0.53
5.1
3.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
8
60
1.40
0.43
11.9
2.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
15
0.00
0.42
0.0
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
0
16
0.00
0.42
0.0
8.1
—
0.3
—
0
10
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
16
0.00
0.42
0.0
1.4
—
4.2
—
0
5
(3011897) Casein IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
2.4
—
7.9
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
67
1.42
0.41
1.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
9
67
1.42
0.41
1.9
1.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
13
99
1.42
0.41
8.7
5.2
e6/l
1.9
1.6
—
7
61
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
18
150
1.31
0.32
3.7
2.9
mmol/mol
32.7
35.7
0.89
11
136
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
55
1.32
0.31
1.1
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
72
1.30
0.28
1.6
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
12
97
1.31
0.26
9.2
5.5
e6/l
1.5
0.5
—
6
58
(36660697) Celiac disease serology panel - Serum
8
101
0.75
0.24
1.0
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
5
42
1.21
0.22
6.6
4.6
nmol/l
15.4
20.9
—
5
42
(3022670) pH of Venous cord blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.4
—
36.4
—
0
10
(3034770) Mitochondria Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
13
0.00
0.21
0.0
44.0
—
11.4
—
0
13
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.6
—
0.7
—
0
13
(40765089) Chromosome analysis panel - Blood by G-banded
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
52
1.17
0.20
2.2
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
11
92
1.25
0.18
9.4
3.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
11
92
1.25
0.18
1.7
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
9
78
1.19
0.16
1.9
2.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
26
242
1.15
0.13
5.1
4.7
mm/h
7.0
8.4
0.33
21
222
(3003694) ABO and Rh group [Type] in Blood
15
134
1.17
0.12
1.8
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
82
1.12
0.07
2.1
2.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
41
415
0.93
0.07
4.1
3.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
13
141
0.89
0.06
2.8
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
19
201
0.91
0.06
2.1
1.8
g/l
1.6
1.3
—
10
87
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
0.8
—
0
6
(3018405) Lactate [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
7.5
—
1.7
—
0
6
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
0
7
0.00
0.00
0.0
1.0
—
175.7
—
0
7
(3045414) Leukocytes [Presence] in Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
3.4
—
0
8
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
60
1.00
0.00
2.2
2.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
0
8
0.00
0.00
0.0
2.1
—
67.0
—
0
8
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
2.4
—
0
8
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
5
57
0.86
0.00
2.0
1.7
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
112.5
—
0
8
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4062490)
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
5.2
—
0
8
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
3.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
10.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: P16_INTRACR_NONTRAU_HAEMORRHAGE_FETUS_NEWBO – Intracranial nontraumatic haemorrhage of fetus and newborn

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data